EV/EBITDA
109.51
+0.51+0.47%
Fri, 29 Nov 2024 21:59:26 GMT
Summary:
Akebia Therapeutics EV/EBITDA is currently 109.51, with a rise of +0.51 (+0.47%) during the most recent trading day. Over the past year, it has increased by +123.07 (+907.60%). AKBA EV/EBITDA is now -57.35% below its all-time high of 256.75.AKBA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | +0.5% |
1 m1 month | +23.7% |
3 m3 months | +53.7% |
6 m6 months | -22.8% |
ytdytd | +467.2% |
1 y1 year | +907.6% |
5 y5 years | +4263.9% |
AKBA EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 109.51 | at high | 86.61 | +26.4% |
3 m | 3 months | 109.51 | at high | 61.23 | +78.8% |
6 m | 6 months | 162.34 | -32.5% | 44.05 | +148.6% |
1 y | 1 year | 256.75 | -57.4% | -55.60 | +297.0% |
3 y | 3 years | 256.75 | -57.4% | -55.60 | +297.0% |
5 y | 5 years | 256.75 | -57.4% | -55.60 | +297.0% |
alltime | all time | 256.75 | -57.4% | -55.60 | +297.0% |
Akebia Therapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | 109.51(-467.2%) |
2023 | -29.82(+935.4%) |
2022 | -2.88(+68.4%) |
2021 | -1.71(+87.9%) |
2020 | -0.91(-69.2%) |
Date | Value |
---|---|
2019 | -2.95(-6.9%) |
2018 | -3.17(-62.2%) |
2017 | -8.39(+431.0%) |
2016 | -1.58(-72.0%) |
2015 | -5.64(+4.6%) |
2014 | -5.39 |
FAQ
- What is Akebia Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akebia Therapeutics?
- What is AKBA EV/EBITDA year-to-date change?
- What is Akebia Therapeutics EV/EBITDA year-on-year change?
What is Akebia Therapeutics EV/EBITDA?
The current EV/EBITDA of AKBA is 109.51
What is the all time high EV/EBITDA for Akebia Therapeutics?
Akebia Therapeutics all-time high EV/EBITDA is 256.75
What is AKBA EV/EBITDA year-to-date change?
Akebia Therapeutics EV/EBITDA has changed by +139.33 (+467.24%) since the beginning of the year
What is Akebia Therapeutics EV/EBITDA year-on-year change?
Over the past year, AKBA EV/EBITDA has changed by +123.07 (+907.60%)